Vitamin B12 and bone loss
This article was originally published in The Tan Sheet
Low serum levels of vitamin B12 in elderly women is associated with more rapid bone loss from the hip than women with higher levels of vitamin B12, but is not associated with greater heel-area (calcaneal) bone loss, Katie Stone, University of California, San Francisco, et al. find in the March Journal of Clinical Endocrinology & Metabolism. The retrospective cohort study was completed by 77 women, age 65 or older. At baseline visit, women gave a blood sample, had a calcaneal bone mineral density measurement and completed a questionnaire on supplement use and food frequency. Repeat measurements of calcaneal and hip BMD were repeated 3.5 and 5.9 years later. The collection of serum samples before measurement of change in bone mass is one of the study's strengths, researchers say...
You may also be interested in...
Pacific Biosciences of California and Aziyo Biologics both acquire new finance chiefs; Illumina hires a new chief marketing officer; WishBone Medical president moves over to take helm at Electromedical Products International; and more.
Complex active ingredients, formulations, routes of delivery, and drug-device combination products are to receive greater attention as part of attempts to facilitate competition after the US FDA awarded a $5m grant to establish a dedicated research center.
In October, the period during which Mylan may complete its merger with Upjohn will begin, while the FDA will begin holding monthly stakeholder meetings ahead of the third iteration of the Generic Drug User Fee Amendments program, also known as GDUFA III.